{"id":"W2019089983","doi":"10.1158/0008-5472.sabcs-09-5114","title":"Pertuzumab and Trastuzumab: Re-Responses to 2 Biological Agents in Patients with HER2-Positive Breast Cancer Which Had Previously Progressed during Therapy with Each Agent Given Separately: A New Biological and Clinical Observation.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Regional Cancer Foundation; BC Cancer Agency; Sunnybrook Health Science Centre","funders":"","keywords":"Pertuzumab; Trastuzumab; Medicine; Oncology; Internal medicine; Cohort; Metastatic breast cancer; Breast cancer; Cancer; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001424103,0.0004019727,0.0007823709,0.0003481057,0.0002714384,0.0001498799,0.0003194532,0.0002980024,0.0003405096],"category_scores_gemma":[0.0003362866,0.0002474945,0.0000540693,0.001441198,0.0005787105,0.0001665319,0.000168928,0.001215268,0.000009743968],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001114964,"about_ca_system_score_gemma":0.001747756,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001584272,"about_ca_topic_score_gemma":0.0009287617,"domain_scores_codex":[0.9946032,0.001034418,0.0005693322,0.001313161,0.001238924,0.001240931],"domain_scores_gemma":[0.9970831,0.0003831332,0.00009913877,0.0004577406,0.0009902705,0.0009865864],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03748339,0.0009385481,0.9031129,0.00005886729,0.0001400865,0.0001444376,0.001374348,0.00001175779,0.0005460023,0.000003113084,0.0007689539,0.05541762],"study_design_scores_gemma":[0.008146276,0.01286562,0.975897,0.001019029,0.00001783498,0.00002706493,0.0002157185,0.00003601583,0.0003692203,0.00001275621,0.00107463,0.0003187911],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9815622,0.002200005,0.000006705908,0.01168972,0.0000359475,0.004298599,0.00009690275,0.0000477219,0.00006218358],"genre_scores_gemma":[0.9920927,0.005524398,0.0003492877,0.0005959896,0.000243634,0.0006711911,0.00003576697,0.00004817978,0.0004388201],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07278417,"threshold_uncertainty_score":0.9999977,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.228070954439714,"score_gpt":0.4791410790961227,"score_spread":0.2510701246564087,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}